Immune-Modified Glasgow Prognostic Score Predicts Therapeutic Effect of Pembrolizumab in Recurrent and Metastatic Head and Neck Cancer.
Ueda N, Kuroki M, Shibata H, Matsubara M, Akita S, Yamada T, Kato R, Iinuma R, Kawaura R, Okuda H, Terazawa K, Mori K, Saijo K, Ohashi T, Ogawa T.
Ueda N, et al. Among authors: kato r.
Cancers (Basel). 2024 Dec 3;16(23):4056. doi: 10.3390/cancers16234056.
Cancers (Basel). 2024.
PMID: 39682242
Free PMC article.